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Attitudes towards oriental medicine are changing for two major reasons. The first is that many
patients, even in the West, are choosing to use its practitioners and methods. The second is that
the rise of Systems Biology may offer a better basis for dialogue, and even for synthesis,
between the oriental and Western traditions. However, a lot of work is needed to clear the
way for such dialogue and synthesis. Much of this work should be devoted to clarifying the
meanings of the terms used, and the framework of theory and practice within which oriental
methods operate. But it is also necessary for Systems Biology itself to mature as a discipline,
particularly at the higher levels of biological organization since it is at these levels that oriental
medicine derives its ideas and practice. Higher level Systems Biology could be a basis for
interpretation of the Korean version of oriental medicine: Sasang constitutional medicine
since it seeks patient specific analysis and treatment, and the mathematical methods of systems
biology could be used to analyze the central concept of balance in Sasang.
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Introduction
Many of the problems in understanding between different
medical traditions arise from language and translation.
I start this commentary, therefore, with some definitions
and clarifications. I will refer to the empirical science-
based medical practice developed in the West over the
last two centuries as Western medicine. Of course, it is
now practiced around the world and much of the scientific
research underlying it occurs today in the East as well
as in the West. Similarly, traditional oriental medicine
(TOM) in its various forms is now practiced worldwide,
but it is still convenient to characterize it by its oriental
origins. These definitions are straightforward and widely
understood. Unfortunately, that does not apply to the
terms and methods used in the two traditions. It is a fun-
damental mistake to translate the terms used in oriental
medicine as simple references to identifiable components
within the anatomy and physiology of Western medicine
[see for example, the comments in Kim and Pham (1) on
the meanings of the Chinese characters usually translated
as spleen, pancreas, kidney, lung and liver, and the earlier
and ground-breaking work of Porkert (2)]. I will return to
these translation problems later.
Until recently, the two traditions have been viewed by
many as incompatible alternatives. But two current
trends in medical science and practice have made it
important to reconsider the relationship between
Western medical science and TOM in its various forms.
We may eventually need a synthesis of the two
approaches. Since this issue of the journal is devoted to
Sasang constitutional medicine (SCM), the article ends
with specific reference to this form.
Patient Choice
The first is a trend in practice. What in the West we refer
to as complementary and alternative medicine (CAM)
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properly cited.has seen a very significant growth in practice, as more
patients are choosing to go to practitioners of these meth-
ods. As Kim and Pham (1) note in their article, this trend
has also been seen in oriental countries. Naturally,
within Korea, this has focused on the uniquely Korean
form of TOM, SCM (four types) (3,4). In Japan, Kampo
(the Japanese version of TOM) is now taught in many
medical schools (5–7). Similar trends have been seen in
China.
There may be multiple causes for this trend in practice;
however, high amongst these causes must be frustration
with the fact that, while the reductive scientific approach
has seen spectacular advances in treating what we might,
misleadingly, call simple diseases (i.e. ones with simple
causes, even if the disease itself is complicated), there
has been a perception that we are failing to advance as
rapidly on diseases with multiple causes. These notably
include cardiovascular disease, metabolic disease, nervous
and psychological diseases and cancer. And even diseases
with a simple cause, like HIV, are proving difficult to
treat.
Actually, this perception is not fully justified. Cancer
was once seen as a death sentence. In many cases it can
now be successfully treated. Similarly, significant progress
has occurred in the treatment of cardiovascular disease.
But these developments have failed to keep up with
a major change in population profile. In developed
countries, this has shifted towards longevity. As people
reach ages at which multiple-cause diseases are more
likely, the number of cases of age-related disease inevit-
ably rises. This simple statistical fact explains the paradox
that while great advances have been made, many more
patients are presenting with these complex diseases.
We succeed spectacularly in keeping people alive through
the ages at which death from infectious diseases was
formerly prevalent, to see them arrive years later in the
clinics as patients with multifactorial diseases. To the
patient, this might seem like a failure when, instead of
a simple drug, like an antibiotic, curing their disease, he
or she finds a more nuanced reaction involving multiple
tests and more tentative, even experimental, forms of
treatment. It is not surprising that patients then turn to
other forms of medical practice. This can be character-
ized as the negative reason for turning to CAM or TOM.
They are seen as alternatives to the failures of Western
medicine.
I suspect though that there is also a positive reason.
People may well be choosing CAM or TOM because
they prefer its philosophical and social basis; it is per-
ceived to pay more attention to the patient. The major
successes of Western medicine have been reductive in
approach: to discover the low-level cause of the disease
and treat it. If the low-level cause is an invading orga-
nism or a lack of a nutrient, or hormone, or too much of
a particular chemical, then the treatment often works.
The problem is that this encourages treatment of the
disease while ignoring the particular patient who has
the disease. The approach is not, of course, intended to
be dehumanizing but, in many contexts where time and
money are short, it does in fact lead to such a perception,
even becoming the undeniable reality. This is the kind of
situation that was immortalized in the best-selling novel,
The House of God (8), which initially scandalized
many medical practitioners in America for its irreverent
uncovering of shocking treatment of, and attitudes
towards, elderly patients, but which has now become
standard reading in many medical schools and the subject
of serious articles and books on the ethics of medicine
(9,10). Incidentally, the real Samuel Shem was a doctoral
student in my Oxford laboratory before practicing medi-
cine in the USA. I have watched this particular argument
in Western medicine at close hand and with unusual
interest.
This argument applies with particular force to SCM
since it specifically characterizes the patient first, by
assigning a category, and then deciding on treatment.
It can therefore be seen as an early form of patient-
specific medicine. Later in this article I will ask the ques-
tion what it must do to remain so.
The Metaphorical Nature of Current Ideas
on Genes and Organisms
The dehumanizing philosophy also lies deep inside the
metaphorical language widely used to convey the results
of Western medical and biological science to the general
public. The hugely popular book, The Selfish Gene, illus-
trates the problem. The organism, the person, is reduced
to a merely transient vehicle for the ‘real’ enduring enti-
ties, its genes, which ‘created us, body and mind’ (11).
And in case that message was not fully absorbed,
Richard Dawkins re-iterated it with even more emphasis
in The Extended Phenotype: ‘[Readers] should imbibe
the fundamental truth that an organism is a tool of
DNA rather than the other way round’ (12). Later,
highly significant, qualifications, such as ‘Genes aren’t
us’ (13) have failed to redress the damage. We now
have a culture that looks for ‘genes for everything’ and
which hailed the sequencing of the human genome as
‘reading the book of life’.
There is in fact no justification in medical and biologi-
cal science for any of these metaphors. The test for this is
simple. Choose alternative, integrative rather than reduc-
tive, metaphors and ask the question ‘what empirical
evidence could there be that one or the other is correct?’
As I show in my book, The Music of Life (14), there are
no such empirical tests. This is not science, although it
masquerades as science and is widely perceived to be so.
Therein lies the problem. We have been seriously misled.
So much, so that when the Human Genome Project
reached its first complete drafts in 2000 the publicity
6 Synthesis between Systems Biology and SCMsurrounding this phenomenal technical and scientific
achievement promised that reading ‘the book of life’
would see new cures for disease naturally emerge from
reading the ‘book’; cures literally tumbling out with
hundreds of new identified targets for therapy. The real-
ity however is that even fewer new drugs are coming
to market and at ever greater cost. There is something
wrong therefore with the way in which these scientific
achievements have been presented.
Systems Biology
This leads me to the second relevant trend, which is the
development of what is now called Systems Biology.
Identifying the individual genes and proteins that are
found in living systems can be viewed as breaking the
system down into its ultimate components. That is why
we characterize this approach as reductionist. But can the
organism actually be reduced to these components? Or is
this not rather like taking a hammer to a computer and
breaking it up into its millions of transistors and wires?
Looking at those components arrayed on a laboratory
bench, would we know how the computer worked? The
answer is obviously ‘no’. We would need the blueprint
for putting it all back together again. We would also
need the software called the operating system, and all
the various programs that make it function. One of the
hopes of the genome project was that, within the
sequences of DNA we would find the ‘program of life’
to use Monod and Jacob’s colorful metaphor (15).
But what we actually find is more like a database, a set
of templates for the construction of proteins and a set of
switches that need to be turned on or off to make the
system work.
It turns out that crucial information for interpreting
the database lies within the rest of the cell, not just in
the DNA sequences. I have recently reviewed this ques-
tion in some depth (16). Genes, interpreted narrowly as
sequences of DNA, need the fertilized egg cell to be inter-
preted, just as a virus cannot operate and reproduce out-
side a living cell. And later in development, interaction
with the rest of the organism and with the environment is
critical in determining the nature of the organism.
Organisms are interaction machines not Turing machines
blindly following a step-by-step program.
Even the architects of the Human Genome Project say
exactly this. In his fascinating biography, Craig Venter
writes ‘One of the most profound discoveries I have
made in all my research is that you cannot define a
human life or any life based on DNA alone......’.
Why? Because ‘An organism’s environment is ultimately
as unique as its genetic code’ (17). Precisely so and, one
should add, the environment is an open system.
John Sulston is also cautious: ‘The complexity of con-
trol, overlaid by the unique experience of each individual,
means that we must continue to treat every human
as unique and special, and not imagine that we can
predict the course of a human life other than in broad
terms’ (18).
Sequencing the human genome has therefore brought
us right up against the problem of complexity in biologi-
cal systems. This is the challenge that 21st century biol-
ogy faces. Its foundations must therefore be built on how
to integrate our knowledge, rather than simply follow a
reductive mode. Having broken life down into its molecu-
lar components, the greater problem is going to be how
to put those components back together again and to
understand the logic of life at all the various biological
levels. This raises difficult questions. Building is far more
difficult than breaking up. This is the domain of Systems
Biology. It is not an entirely new discipline. In fact
I would identify its origins as being, first, with the 19th
century French physiologist Claude Bernard (19), who
introduced the idea of control of what he called the
internal environment, and thus the concept of homeo-
stasis (20). It can also be seen as originating in the
early applications of mathematics to biological systems,
notably the analysis of the nerve impulse by Hodgkin and
Huxley (21). Complexity absolutely requires mathematics
since, beyond a certain number of interactions between
components, intuition (guesswork) fails us. We need to
calculate the expected behavior of a system. Systems
Biology has therefore been greatly advanced by the devel-
opment of fast, powerful computers (22).
Although we can identify these historical roots, Systems
Biology has really taken off only recently (23–28). It is
therefore a relatively young initiative and it is far too
early to judge how successful it may be in avoiding and
resolving the difficulties of the reductionist approach.
Nevertheless, there are encouraging signs in the analysis
of new drugs developed within the pharmaceutical indus-
try (29). Significantly, some of these are drugs with mul-
tiple actions, an approach that can also be seen to be
important in herbal medicine, which forms a major part
of oriental medicine. This approach is also leading to the
development of what are called virtual organs and sys-
tems: reconstruction of the function of whole organs and
systems as part of a project called the Human Physiome
Project (30,31). The European version of this is actually
called the Virtual Physiological Human.
The really significant philosophical difference between
Systems Biology and reductionist biology is that Systems
Biology focuses on processes rather than components.
It is in this sense more holistic, though I have reserva-
tions about the word ‘holistic’ in this context [see also
(32)]. Systems Biology, it seems to me, is rather a multi-
level analysis of biological processes (20,30). It is cer-
tainly not simply a top–down analysis, as the word
‘holistic’ may suggest. It may respect holistic approaches
more than does reductionist biology, but it is not itself
strictly a holistic method. For related reasons, it is not
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inherent in the set of components, but which only appear
when they interact. It was Sydney Brenner who coined
the phrase ‘middle-out’ to emphasize that the approach is
neither bottom-up nor top-down. Function at higher
levels in organisms depends on an interaction between
the genome, the cells, tissues and organs, and the envi-
ronment, with the higher levels and the environment
acting as constraints on the processes at lower levels.
Without those constraints life could not exist. There is
no privileged level of causality (16,20).
Conditions for Dialogue and Synthesis
Could Systems Biology form the basis for some kind of
dialogue at least, and perhaps even a synthesis, between
the Western and oriental traditions, as suggested for
example by Jane Qiu (33)? This was the subject of a
meeting held in Oxford recently at which scientists from
both traditions were present. There was general agree-
ment that System Biology, and particularly the existence
of ‘downward causation’ (i.e. higher level constraint of
lower level processes), does open up the possibility of
constructive dialogue between the Western and oriental
medical traditions in a way that was not possible within
the dominant reductive mode of biology.
The reasons for this agreement were:
1. The characterization of forms of ‘downward causa-
tion’, including both feedback and constraint, could
be a way of linking the two traditions.
2. Systems Biology can identify multiple actions
as being more beneficial than single site actions
[e.g. multiple action drugs within the Western
medical tradition, most recently ranolazine—see
(29), and the use of synergistic drug combinations
(34)]. This could open the way to a better under-
standing of, and development of, herbal medicine,
since this also depends on synergistic actions of
multiple components.
3. Systems Biology recognizes the importance of con-
trol of the genome by higher levels (via epigenetic
marking and control) including even the role of
behavioral and social factors. This can be seen, for
example, in the work of Weaver et al. (35–37) on
epigenetic inheritance of stroking behavior in rats.
This form of downward causation spans all the
levels of biological organization and could open
the way to dialogue on the central role of the
mind in oriental Medicine.
4. Korean Sasang can be viewed as a patient specific
form of treatment. Genomics and Systems Biology
are also looking towards the development of patient
specific medication and treatment. However,
Systems Biology is not looking towards ancient
Galenic or other interpretations of constitution.
The question therefore arises whether oriental med-
icine could be open to investigation on this ques-
tion? I think it can. Kim et al. (38) chart the way
forward in applying genomics to SCM.
5. Could oriental medicine become consistent with the
need for regulation and clinical trial evidence? There
are already examples of successful clinical trials of
acupuncture for pain relief and of meditation ther-
apy for depression. Oriental medicine should not be
fearful of clinical trials, though it has to be admitted
that there are special difficulties in establishing
effective controls in such trials. The correct placebo
for a treatment like acupuncture is much more diffi-
cult to arrange than is a sugary pill!
6. But perhaps, as noted in my introduction, the big-
gest problem is historical and cultural. In the West,
oriental medicine is thought by many people to
include many kinds of ‘magic’, mysterious effects
that are perceived as anti-scientific. This raises
the question whether oriental medicine could be
de-mythologized?
What do I mean by demythologizing? I mean whether it
would be possible to map concepts like (ki, qi), that at
first sight closely resemble that of ‘vital energy’, to
systems-level concepts that are empirically testable and
do not simply resurrect the old concept of vital energy,
a concept that was specifically rejected by scientists like
Claude Bernard. There are similar questions with con-
cepts such as (jing essence?), (shen spirit?),
(yin), (yang), (mai vessel), and as Kim and Pham
show (1), for the various Chinese characters for organ
systems. My proposal is that we might more profitably
identify these with systems processes not as separate
substances. In this context, it is interesting that in a
recent study of the practice of Traditional Chinese
Medicine in modern China, Hsu (39) ends with the
conclusion:
It was the process which brought about dishar-
mony, not the material aspects....this concep-
tion of the body in its disordered state was
common to qigong and Chinese medicine
Conclusions
I suggest that dialogue and synthesis will need to take
place in several stages:
(a) Translation and interpretation. The outlines for
some of this work are already clear (1,2,39–42).
A good example of the approach required is to
be found in Lu and Needham’s study of acupunc-
ture and moxibustion, relating the historical orien-
tal texts to interpretations using modern biology
(43). There is a solid base, therefore, on which to
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not as simple as producing a better dictionary
of oriental medical terms. Those terms acquire
their meanings within a complete semantic frame,
in turn determined by historical and sociological
backgrounds that need to be understood.
Moreover, translation and interpretation depends
not only on understanding the source language,
but also on the target language into which the
interpretation is done. An important conclusion
of this article is that the language of Systems
Biology is still developing. Since we do not yet
know the higher-level concepts that will form its
foundations in the future, we cannot yet know
what would be the best way to map oriental
medical concepts onto those of Systems Biology.
The processes of translation and interpretation
are therefore on-going tasks, working within the
frameworks of the two cultures involved, each of
which is developing.
(b) An essential component of future work will there-
fore be the development of Systems Biology in a
direction that enables understanding of physio-
logical and pathological processes at the higher
levels of organization. We are a long way from
achieving this at the current time. The greater
effort and funding in Systems Biology is at
the lower levels of gene–protein networks. The
Physiome Project attempts to redress the balance
here, but it also is a long way from integrating
together organ systems that could correspond,
for example, to those postulated by SCM and
TOM in general.
(c) The application of Systems Biology to oriental
medicine. Systems Biology is a highly quantitative
discipline. Some even define it in terms of the ways
in which mathematics is applied to biology. In
addition to molecular biology, genomics, proteo-
mics and bioinformatics, it also has roots in bio-
logical engineering and in mathematical biology.
It is nothing less than a revolution in biology,
bringing to it the same rigor as mathematics has
brought to physics, engineering and chemistry.
oriental medicine, by contrast, is not mathemati-
cal, though concepts of balance of the kind
discussed in some of the articles in this volume
could obviously be expressed mathematically.
I suspect therefore that, in addition to changing the
nature of modern biological science, Systems Biology
may eventually also change the nature, or at least the
characterization of TOM. This conclusion is particularly
relevant to the tradition of SCM. It could examine its
fundamental basis in two ways. The first, as outlined
by Kim et al. (35), is that the concept of constitu-
tional types could be re-examined via genomic studies.
The main challenge here will be that the concepts of con-
stitutional type at the phenotype level (as in Sasang) and
at the genomic level are different since there is no simple
relation between genotype and phenotype. The causal
links are complex (15). But Sasang scientists are in a
good position to do this work since they have access to
patients who are naturally classified according to pheno-
type constitutional group. Relating these classifications
to genotypes would be a very important first step. The
second is that the concept of balance between systems
could be treated mathematically, just as Claude Bernard
(18,19) envisioned the mathematical analysis of his con-
cept of homeostasis, the processes that maintain the con-
stancy (via various forms of balance) of the internal
environment. As the Physiome Project advances, such
an application to the balance concept in Sasang could
become possible.
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